Subgroups in the treatment of nasal polyposis with dupilumab: A retrospective study-Reference-Cited by-同舟云学术

Subgroups in the treatment of nasal polyposis with dupilumab: A retrospective study

Published:2022-11-11 Issue:45 Volume:101 Page:e31031
ISSN:1536-5964
Container-title:Medicine
language:en
Short-container-title:

Author:

Bertlich Mattis,Freytag Saskia,Dombrowski Tobias,Jurmeister Philipp,Spiegel Jennifer Lee,Bertlich Ines,Ihler Friedrich,Weiss Bernhard G.,Haubner Frank,Gröger Moritz

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference26 articles.

1. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis;Hopkins;Laryngoscope,2009

2. Surgery in Nasal polyp patients: outcome after a minimum observation of 10 years;Vlaminck;Am J Rhinol Allergy,2021

3. Subclassification of chronic rhinosinusitis;Han;Laryngoscope,2013

4. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers;Tomassen;J Allergy Clin Immunol,2016

5. A comparative and descriptive study of asthma in chronic rhinosinusitis with nasal polyps;Håkansson;Am J Rhinol Allergy,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps;European Archives of Oto-Rhino-Laryngology;2024-06-08

2. Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature;European Archives of Oto-Rhino-Laryngology;2024-05-19

3. The value of biomarkers in the therapy of CRSwNP with biologicals—a long-term follow-up of dupilumab therapy;European Archives of Oto-Rhino-Laryngology;2024-05-06

4. Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report;European Archives of Oto-Rhino-Laryngology;2023-11-01

5. Dupilumab‐induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis;Allergy;2023-08-07